![Larry Shimp](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Larry Shimp
Hoofd Techniek/Wetenschap/O&O bij Osteotech, Inc.
Profiel
Larry Shimp is currently the Chief Technology Officer at Osteotech, Inc. He previously worked as a Scientist at FMC Corp.
Dr. Shimp holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from Northwestern University.
Actieve functies van Larry Shimp
Bedrijven | Functie | Begin |
---|---|---|
Osteotech, Inc.
![]() Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Hoofd Techniek/Wetenschap/O&O | 01-05-1992 |
Eerdere bekende functies van Larry Shimp
Bedrijven | Functie | Einde |
---|---|---|
FMC CORPORATION | Corporate Officer/Principal | - |
Opleiding van Larry Shimp
Massachusetts Institute of Technology | Doctorate Degree |
Northwestern University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
FMC CORPORATION | Process Industries |
Bedrijven in privébezit | 1 |
---|---|
Osteotech, Inc.
![]() Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Health Technology |